In selected TN patients without V1 involvement, AST provides effective pain control with comparable 12-month outcomes to DREZ and shorter beam-on time. Given its relative distance from the brainstem and reduced V1 inclusion, AST may be considered for initial or repeat GKRS in selected cases.
Erdem et al. (Fri,) studied this question.